The use of low-dose prednisone in the management of rheumatoid arthritis

S. Sam Lim, Doyt L. Conn, Marc T. Galloway, Jimmy H. Hara, Donna Hawley, Deborah W. Kredich, Nancy Olsen, Richard S. Panush, Leonard H. Sigal, Daniel J. Wallace

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Low doses of prednisole are safe and effective in the management of RA. Yet, some clinicians continue to manage their RA patients with glucocorticoid doses that are too high or avoid them altogether. Glucocorticoids in low doses have proven to be very effective in suppressing the inflammation associated with RA. In addition, there is good evidence that low doses of prednisolone retard bony erosions of RA. Potential side effects of low doses of glucocorticoids can be anticipated and avoided with prudent preventative measures and appropriate management. Therefore, prednisole should be initiated as early as possible in the treatment of RA usually with another DMARD. Treatment of the inflammation in RA should not exceed 10 mg/day and often may need to be given in daily divided doses (5 mg BID). Supplemental daily calcium at 800-1,000 mg/day and vitamin D at 400-800 units/day should always be initiated with treatment. Tapering of prednisole should be done slowly using 1 mg decrements every couple weeks to a month. One should not deem it a failure to hold the patient on the lowest effective dose of prednisole.

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalBulletin on the Rheumatic Diseases
Volume50
Issue number12
StatePublished - Dec 1 2001

Fingerprint

Prednisone
Glucocorticoids
Rheumatoid Arthritis
Inflammation
Antirheumatic Agents
Prednisolone
Vitamin D
Therapeutics
Calcium

All Science Journal Classification (ASJC) codes

  • Rheumatology

Cite this

Lim, S. S., Conn, D. L., Galloway, M. T., Hara, J. H., Hawley, D., Kredich, D. W., ... Wallace, D. J. (2001). The use of low-dose prednisone in the management of rheumatoid arthritis. Bulletin on the Rheumatic Diseases, 50(12), 1-4.
Lim, S. Sam ; Conn, Doyt L. ; Galloway, Marc T. ; Hara, Jimmy H. ; Hawley, Donna ; Kredich, Deborah W. ; Olsen, Nancy ; Panush, Richard S. ; Sigal, Leonard H. ; Wallace, Daniel J. / The use of low-dose prednisone in the management of rheumatoid arthritis. In: Bulletin on the Rheumatic Diseases. 2001 ; Vol. 50, No. 12. pp. 1-4.
@article{9f8ac29f9d224ca999ad3be93cd7d96b,
title = "The use of low-dose prednisone in the management of rheumatoid arthritis",
abstract = "Low doses of prednisole are safe and effective in the management of RA. Yet, some clinicians continue to manage their RA patients with glucocorticoid doses that are too high or avoid them altogether. Glucocorticoids in low doses have proven to be very effective in suppressing the inflammation associated with RA. In addition, there is good evidence that low doses of prednisolone retard bony erosions of RA. Potential side effects of low doses of glucocorticoids can be anticipated and avoided with prudent preventative measures and appropriate management. Therefore, prednisole should be initiated as early as possible in the treatment of RA usually with another DMARD. Treatment of the inflammation in RA should not exceed 10 mg/day and often may need to be given in daily divided doses (5 mg BID). Supplemental daily calcium at 800-1,000 mg/day and vitamin D at 400-800 units/day should always be initiated with treatment. Tapering of prednisole should be done slowly using 1 mg decrements every couple weeks to a month. One should not deem it a failure to hold the patient on the lowest effective dose of prednisole.",
author = "Lim, {S. Sam} and Conn, {Doyt L.} and Galloway, {Marc T.} and Hara, {Jimmy H.} and Donna Hawley and Kredich, {Deborah W.} and Nancy Olsen and Panush, {Richard S.} and Sigal, {Leonard H.} and Wallace, {Daniel J.}",
year = "2001",
month = "12",
day = "1",
language = "English (US)",
volume = "50",
pages = "1--4",
journal = "Bulletin on the Rheumatic Diseases",
issn = "0007-5248",
publisher = "Arthritis Foundation",
number = "12",

}

Lim, SS, Conn, DL, Galloway, MT, Hara, JH, Hawley, D, Kredich, DW, Olsen, N, Panush, RS, Sigal, LH & Wallace, DJ 2001, 'The use of low-dose prednisone in the management of rheumatoid arthritis', Bulletin on the Rheumatic Diseases, vol. 50, no. 12, pp. 1-4.

The use of low-dose prednisone in the management of rheumatoid arthritis. / Lim, S. Sam; Conn, Doyt L.; Galloway, Marc T.; Hara, Jimmy H.; Hawley, Donna; Kredich, Deborah W.; Olsen, Nancy; Panush, Richard S.; Sigal, Leonard H.; Wallace, Daniel J.

In: Bulletin on the Rheumatic Diseases, Vol. 50, No. 12, 01.12.2001, p. 1-4.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The use of low-dose prednisone in the management of rheumatoid arthritis

AU - Lim, S. Sam

AU - Conn, Doyt L.

AU - Galloway, Marc T.

AU - Hara, Jimmy H.

AU - Hawley, Donna

AU - Kredich, Deborah W.

AU - Olsen, Nancy

AU - Panush, Richard S.

AU - Sigal, Leonard H.

AU - Wallace, Daniel J.

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Low doses of prednisole are safe and effective in the management of RA. Yet, some clinicians continue to manage their RA patients with glucocorticoid doses that are too high or avoid them altogether. Glucocorticoids in low doses have proven to be very effective in suppressing the inflammation associated with RA. In addition, there is good evidence that low doses of prednisolone retard bony erosions of RA. Potential side effects of low doses of glucocorticoids can be anticipated and avoided with prudent preventative measures and appropriate management. Therefore, prednisole should be initiated as early as possible in the treatment of RA usually with another DMARD. Treatment of the inflammation in RA should not exceed 10 mg/day and often may need to be given in daily divided doses (5 mg BID). Supplemental daily calcium at 800-1,000 mg/day and vitamin D at 400-800 units/day should always be initiated with treatment. Tapering of prednisole should be done slowly using 1 mg decrements every couple weeks to a month. One should not deem it a failure to hold the patient on the lowest effective dose of prednisole.

AB - Low doses of prednisole are safe and effective in the management of RA. Yet, some clinicians continue to manage their RA patients with glucocorticoid doses that are too high or avoid them altogether. Glucocorticoids in low doses have proven to be very effective in suppressing the inflammation associated with RA. In addition, there is good evidence that low doses of prednisolone retard bony erosions of RA. Potential side effects of low doses of glucocorticoids can be anticipated and avoided with prudent preventative measures and appropriate management. Therefore, prednisole should be initiated as early as possible in the treatment of RA usually with another DMARD. Treatment of the inflammation in RA should not exceed 10 mg/day and often may need to be given in daily divided doses (5 mg BID). Supplemental daily calcium at 800-1,000 mg/day and vitamin D at 400-800 units/day should always be initiated with treatment. Tapering of prednisole should be done slowly using 1 mg decrements every couple weeks to a month. One should not deem it a failure to hold the patient on the lowest effective dose of prednisole.

UR - http://www.scopus.com/inward/record.url?scp=0035703156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035703156&partnerID=8YFLogxK

M3 - Article

C2 - 12386945

AN - SCOPUS:0035703156

VL - 50

SP - 1

EP - 4

JO - Bulletin on the Rheumatic Diseases

JF - Bulletin on the Rheumatic Diseases

SN - 0007-5248

IS - 12

ER -

Lim SS, Conn DL, Galloway MT, Hara JH, Hawley D, Kredich DW et al. The use of low-dose prednisone in the management of rheumatoid arthritis. Bulletin on the Rheumatic Diseases. 2001 Dec 1;50(12):1-4.